Overview

PET Assessment of Acute Lung Transplant Rejection

Status:
Terminated
Trial end date:
2017-02-04
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to gain understanding of the basic responses of the lungs to inflammation and specifically if there may be a better way to detect graft inflammation using non-invasive methods as well as to determine the effectiveness of immunosuppressive treatment regimens in preventing acute rejection in lung transplant recipients.
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Fluorodeoxyglucose F18